CHAT, a novel 18-item patient-reported questionnaire, shows promise as a clinical and research tool for evaluating cough ...

The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...

Several featured studies demonstrate how AI systems are outperforming conventional diagnostic protocols, particularly in ...

Hyderabad: Niloufer Hospital in Hyderabad became the first in the country to launch 'Amruth Swasth Bharath,'' the first ...

The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...

A team of researchers from Keio University School of Medicine, Kyoto Prefectural University of Medicine, and Teikyo ...

Preliminary results from a different ongoing study suggest that the VeriStrat test may have similar indications in patients with other types of solid tumors. Data from this study is expected to be ...

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...

The presentation titled “ Time to Diagnosis of Lung Cancer from Identification of a Pulmonary Nodule in the United States ” was presented yesterday by Kimberly Le, Biodesix Director of Health ...

The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...

This gap underscores the need for more standardized, objective evaluation tools—and highlights ... demonstrated high diagnostic accuracy. In a validation study using 220 test images, the AI ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...